April 17, 2025 8:18 PM

Latest:

China’s Export Cutoff May Lead To Rare Earth Rush, US Scrambles for Seabed Minerals
China’s 25,000 Ton Gold Stash: Preparing to Kill the Dollar? | Craig Hemke
Trump Considers Delay on Auto Parts Tariffs
Trump Again Targets Critical Minerals Amid US Supply Chain Gaps
Another California Refinery Closure Looms Amid Regulatory Pressures

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

Liberal Government Two More Canadian Cabinet Ministers Exit as Pre-Election Exodus Grows

Latest

China’s Export Cutoff May Lead To Rare Earth Rush, US Scrambles for Seabed Minerals
China’s 25,000 Ton Gold Stash: Preparing to Kill the Dollar? | Craig Hemke
Trump Considers Delay on Auto Parts Tariffs
Trump Again Targets Critical Minerals Amid US Supply Chain Gaps
Another California Refinery Closure Looms Amid Regulatory Pressures
Trump Calls Powell ‘Too Late and Wrong,’ Says Termination ‘Cannot Come Fast Enough’
The Leadership Debate Where Canadians Lost
Tilray Brands Proposes Reverse Split Of Up To 20-To-1 To Regain Nasdaq Compliance

Video

China’s 25,000 Ton Gold Stash: Preparing to Kill the Dollar? | Craig Hemke

April 17, 2025 2:14 PM JP Alegre 0

In this interview, Craig Hemke from TF Metals Report provides a dive into the complex economic tensions between the United

Australia Fills China's Beef Market Gap As Trade War Halts US Exports
RCMP Officers Demand Liberal Cabinet To Resign
Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
Court Finds Rebel News Failed to Prove It’s Real Journalism
Liberals Appoint Wife of Bloc Québécois Leader to Head Federal Research Foundation

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Stocktwits Partners with Beehiiv to Launch Newsletter Platform for Finance Writers

April 16, 2025 2:54 PM JP Alegre 0

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Leave a ReplyCancel reply